MedPath

Turpentine

Generic Name
Turpentine
Drug Type
Small Molecule
CAS Number
9005-90-7
Unique Ingredient Identifier
XJ6RUH0O4G

Overview

Turpentine, also known as spirit of turpentine, oil of turpentine, and wood turpentine, is a liquid extracted from live trees, mainly pine, through distillation of resin. It is used as a solvent and base material in organic synthesis reactions. Turpentine is composed of terpenes, mainly the monoterpenes alpha-pinene and beta-pinene with lesser amounts of carene, camphene, dipentene, and terpinolene.

Indication

Turpentine has been used experimentally in a bath for the treatment of disseminated sclerosis and sexual dysfunction. It also has been studied for its antibacterial activity and inhibition of osteoclast activity. Turpentine is utilized in experimental models of inflammation to induce a systemic inflammatory immune response in animals.

Associated Conditions

  • Joint Pain
  • Myalgia

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
BioActive Nutritional, Inc.
43857-0572
ORAL
12 [hp_X] in 1 mL
5/19/2025
Penleigh Irving Ltd
27426-070
Topical
7.11 g in 147 g
5/7/2025
BM Private Limited
85816-6011
ORAL
3 [hp_X] in 1 mL
7/31/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
VIDA-ANALGESIC BALM
N/A
N/A
N/A
3/11/2006

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
MINARD'S LINIMENT LOT
smithkline beecham consumer healthcare, division of smithkline beecham inc.
01915061
Lotion - Topical
10.5 %
12/31/1992
TEREBINTHINA CHIOS-INJEEL LIQ (12D,30D,200D/1.1ML)
02065002
Liquid - Oral
12 D / 1.1 ML
12/31/1994
TEREBINTHINA LIQUID (S#66) -2,3,6,9,12X...CM
total health centre
02186268
Liquid ,  Drops - Sublingual
2 X / ML
6/1/1997
MEDIMENTOL ONT
hilary's distibution ltd.
00393940
Ointment - Inhalation
390 MG / 28.3 G
12/31/1957
UR-BOSAN B49-LIQ
professional health products
02157764
Liquid - Oral
3 D / ML
12/31/1996
DR THOMAS ECLECTRIC OIL
northrop and mcgillivray ltd.
00394114
Liquid - Topical
47.07 G / 100 G
12/31/1982
TEREBINTHINA GOUTTE 4CH-30CH
dolisos laboratoires s.a.
00685690
Drops - Oral
1 CH / CH
12/31/1987
HOMEOPATHIC MEDICINE (S66) DPS 30C
total health centre
02071177
Drops - Oral
30 C / ML
12/31/1994
CSTIBOSAN B48 - LIQ
professional health products
02158922
Liquid - Oral
5 D / ML
12/31/1996
TEREBINTHINA GOUTTE 1DH - 30CH
boiron laboratoires
00686271
Drops - Oral
1 DH / DH
12/31/1987

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.